NEUROMAX

argeted Neurolitic for Pain Management

Block. Control. Relieve. Regulate.

Key Benefits: 

• Temporarily blocks nerve transmission

• Selective action on type-C fibers

• Precise dosage by nerve size

• Fast-acting neuromodulation

• Minimizes peripheral nerve signals

Product Description:

NEUROMAX 1.5% is a parenteral-use neurolitic agent designed to temporarily inhibit nervous transmission in type-C unmyelinated fibers. Its active ammonium ion acts through ionic competition, selectively blocking thinner nerve fibers involved in pain transmission. The blocking effect is inversely proportional to fiber diameter, enabling targeted and controlled application based on nerve size.

Indications for Use:

• Temporary interruption of nerve signals

• Pain relief through neurolitic effect

• Musculoskeletal or intra-articular applications

• Management of localized neuralgia or inflammation

Route of Administration:

• Subcutaneous (SC)

• Intramuscular (IM)

• Intra-articular (IA)
  (Dosage determined by nerve size and clinical need)

Target Species:

Veterinary use — suitable for species requiring localized neuromodulation under veterinary supervision.

Target Pain. Control Nerve Response. NEUROMAX.
Advanced nerve-blocking technology for precise pain modulation.